OSTEOGROW has already been tested in patients undergoing high tibial osteotomy and in patients with a closed distal radius fracture. Preliminary results and final data analysis indicate that OSTEOGROW accelerates the healing of trabecular bone in humans. Available safety data suggests good OSTEOGROW safety and no serious adverse reactions have been reported in studies to date.

Read more:

  • A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures
    DOI: 10.1016/j.bone.2020.115551
  • Recombinant Human BMP6 Applied Within Autologous Blood Coagulum Accelerates Bone Healing: Randomized Controlled Trial in High Tibial Osteotomy Patients
    DOI: 10.1002/jbmr.4107